Child ’s science experiment solves chronic disease mystery

“Chew this.” I was instructed. “But don’t swallow. Just tell me when IT happens.” IT? What was IT? I’d have to find out. My researcher’s son — who enlisted me in his science experiment — wasn’t telling. So I obliged and started chewing. It tasted just as I expected at first. Bland. Almost cardboard-like. And then the strangest thing occurred. After about a minute, a hint of sweetness tickled my tongue. I kept chewing. A few seconds later, it intensified… like I was sucking on candy. And a few seconds after that it felt like I had an entire spoonful of sugar in my mouth. What happened? Like a shredder rips paper into little strips… my teeth and enzymes in my saliva broke down the complex molecules in the food. In a nutshell, simply chewing the food longer revealed what was REALLY inside the food. Now, the food I was asked to chew was what many people would consider harmless. Some would even call it healthy. A cracker. But as you’ve just seen, essentially it was no different than eating sugar. That’s right… the complex carbohydrates found in starchy foods like rice, pasta, and bread quickly turn into simple carbohydrates that have the same effect on your body as sugar. Which means they have the same harmful health effects on your body that sugar does. But so what? How much sugar can be in a cracker? A lot more than you would think. Just three measly crackers break down into the equivale...
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Nutrition Weight Loss carbohydrates carbs disease sugar Syndrome Zero Source Type: news

Related Links:

CONCLUSION: This study found that childhood cancer survivors in New Zealand had a high prevalence of developmental dental abnormalities and it identified potential risk factors related to their cancer treatment. Inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand. PMID: 33032302 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Publication date: Available online 10 October 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Thejus T. Jayakrishnan, Veli Bakalov, Zena Chahine, John Lister, Rodney E. Wegner, Santhosh Sadashiv
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
Publication date: 15 February 2021Source: Chemical Engineering Journal, Volume 406Author(s): Do Kyung Kim, Sanghyuk Lee, Minjeong Kim, Yunhui Jeong, Soonchul Lee
Source: Chemical Engineering Journal - Category: Chemistry Source Type: research
AbstractLike other malignancies, prostate tumors are thought to contain cancer stem-like cells (CSCs) that are responsible for growth, metastasis, and therapy resistance. ΔNp63 (also called p40) is a regulator of normal prostate stem/progenitor cell activities and a marker of normal basal epithelial cells. The levels of ΔNp63 are reduced in prostate adenocarcinomas, although there is also evidence that ΔNp63 is involved in CSC regulation and drives metastasis to t he bone. We studied metastatic deposits of prostate cancers with isoform-specific ΔNp63 and TAp63 antibodies. We identified p63-positive ...
Source: Virchows Archiv - Category: Pathology Source Type: research
It would dedicate $1.5 billion of its total to research and therapy for Alzheimer ’s Disease, Parkinson’s Disease, stroke, epilepsy and other brain and central nervous system conditions.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Publication date: Available online 8 October 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Ram Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, Zeyad Al-Shaibani, Wilson Lam, Fotios V. Michelis, Dennis Dong Hwan Kim, Auro Viswabandya, Armin Gerbitz, Jeffrey Howard Lipton, Rajat Kumar, Jonas Mattsson, Arjun Datt Law
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
Publication date: Available online 8 October 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): M.M. Sulaiman, A.I. Ladu, A.M. Abba, A.A. Bukar
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
Publication date: Available online 8 October 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Muhammad Bilal Abid, Saurabh Chhabra, Blake Buchan, Mary Beth Graham, Sameem Abedin, Bicky Thapa, Anita D'Souza, Ben George, Mehdi Hamadani
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
ConclusionSOS is relatively rare; therefore, a holistic approach to the patients ’ needs considering nursing role as essential may result in better care outcomes.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
It would dedicate $1.5 billion of its total to research and therapy for Alzheimer ’s Disease, Parkinson’s Disease, stroke, epilepsy and other brain and central nervous system conditions.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
More News: Carbohydrates | Cardiology | Children | Complementary Medicine | Diets | Heart | Insulin | Men | Minerals | Nutrition | Science | Stem Cell Therapy | Stem Cells | Sugar | Vitamins | Weight Loss | Women